Major bleeding and thromboembolic complications associated with antithrombotic treatment in patients with atrial fibrillation/flutter and incident cancer

Background: Anticoagulant management of patients with atrial fibrillation with active cancer is complex because cancer increases the risk of thrombosis as well as bleeding. Previous studies have investigated the impact of any type of cancer, while outcomes may differ per specific type. We performed...

Full description

Bibliographic Details
Published in:Research and Practice in Thrombosis and Haemostasis
Main Authors: Gordon Chu, Nienke van Rein, Menno V Huisman, Lars Pedersen, Henrik T. Sørensen, Suzanne C. Cannegieter, Frederikus A. Klok
Format: Article
Language:English
Published: Elsevier 2025-02-01
Subjects:
Online Access:http://www.sciencedirect.com/science/article/pii/S2475037925000214